BioMarin Takes Legal Action Against Ascendis Pharma Over Patent Rights in Europe BioMarin Pharmaceutical Inc. initiates legal proceedings against Ascendis Pharma A/S for alleged infringement of its European patent concerning C-Type Natriuretic Peptide variants.

BioMarin Takes Legal Action Against Ascendis Pharma Over Patent Rights in Europe #United_States #San_Rafael #Ascendis_Pharma #BioMarin #CNP

Orsini Partners with Ascendis to Distribute YORVIPATH® for Rare Disorder Treatment Orsini has been appointed by Ascendis Pharma as the specialty pharmacy partner for YORVIPATH®, a treatment for hypoparathyroidism in adults, highlighting their commitment to rare diseases.

Orsini Partners with Ascendis to Distribute YORVIPATH® for Rare Disorder Treatment #United_States #Elk_Grove_Village #Ascendis_Pharma #YORVIPATH #Orsini

PANTHERx® Rare Teams Up with Ascendis Pharma for YORVIPATH® Distribution PANTHERx® Rare partners with Ascendis Pharma to distribute YORVIPATH®, a treatment for hypoparathyroidism, providing vital support for patients nationwide.

PANTHERx® Rare Teams Up with Ascendis Pharma for YORVIPATH® Distribution #United_States #Pittsburgh #YORVIPATH® #Ascendis_Pharma #PANTHERx